Obstructive Lung Disease

Is There an “Ideal” Cystic Fibrosis Candidate for Lung Transplantation?

By

Suzanne Bujara

Publish Date August 23, 2018

Lung transplantation can extend survival in patients with cystic fibrosis who have compromised lung function and increasing exacerbations.

Inhaled Messenger RNA Treatment Fast-Tracked for Cystic Fibrosis

By

Steve Duffy

Publish Date March 9, 2020

The FDA has granted Fast Track designation to MRT5005, an inhaled messenger RNA (mRNA) therapeutic being investigated for the treatment of cystic fibrosis.

Ultrasound May Identify Children at Risk for Cystic Fibrosis Liver Disease

Publish Date February 27, 2020

A heterogeneous liver pattern could indicate a higher risk for advanced cystic fibrosis liver disease.

Investigational Antibiotic Receives Orphan Drug Status for CF Pulmonary Exacerbations

By

Steve Duffy

Publish Date February 26, 2020

The FDA has granted Orphan Drug designation to ARV-1801 (sodium fusidate; Arrevus) for the treatment of pulmonary exacerbations in patients with cystic fibrosis.

Continuous Glucose Monitoring in Youth With Cystic Fibrosis May Detect Early Diabetes

By

Pulmonology Advisor Contributing Writer

Publish Date February 3, 2020

Continuous glucose monitoring may provide a better understanding of the early stages of diabetes progression in youth with cystic fibrosis.

Nontuberculous Mycobacterial Infection in Cystic Fibrosis: Treatment Recommendations

By

Brandon May

Publish Date January 13, 2020

A multidisciplinary team discussed exploring the management options for nontuberculous mycobacterial infection in patients with cystic fibrosis.

Differences in BAL Surveillance of Preschool Children With Cystic Fibrosis

By

Sheila Jacobs

Publish Date December 17, 2019

Significant differences have been observed from bronchoalveolar lavage surveillance conducted among preschool children with cystic fibrosis, according to their country of residence.

Diversity of Mycobacterium abscessus Subclones in Pediatric Cystic Fibrosis

By

Bradley van Paridon

Publish Date December 16, 2019

Sputum isolates of Mycobacterium abscessus may not reflect a patient’s full bacterial diversity.

Controlling Antibiotic Adverse Drug Reactions in Cystic Fibrosis

By

Britt Gambino

Publish Date November 8, 2019

The majority of patients with cystic fibrosis experience at least 1 antibiotic adverse drug reaction.